CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update

Go back to CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update

CorMedix (CRMD) Tops Q2 EPS by 2c

August 11, 2022 7:33 AM EDT

CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

... More